
Martijn Arns
@Brainclinics
Followers
4K
Following
2K
Media
491
Statuses
5K
Brainclinics Foundation | Stanford University | Neuroscientist | Entrepreneur | TMS | Psychedelics | Neurofeedback/BCI | Depression | Heart-Brain Coupling |
Palo Alto & Nijmegen (NL)
Joined May 2010
@NatMentHealth Biomarker-driven stratified psychiatry: from stepped-care to matched-care in mental health https://t.co/KIVxEW4F4q First stratification biomarker that helps stratify between antidepressant treatments, taking level of treatment (eg. first-line vs. second-line treatment) into
1
5
29
“I think one of the biggest things that I found is the amount of kids that have sleep-disorder breathing, this can be snoring or sleep apnea or some sort of dysfunction in their breathing at night. And then if you take that population of kids who have these breathing problems at
39
74
823
What a great TMS Masterclass we just had, great engaging group of attendees and speakers from across the globe and learnt a lot on the latest in TMS and Brain Stimulation. A big thanks to our speakers: @JonathanDownar @andreashorn_ Joe Taylor, Joshua Brown, Roel Mocking and
0
0
7
See earlier study that was published on this here: https://t.co/qwzmyq9OVZ With data from two @neurocaregroup clinics from Nijmegen and New York.
brainstimjrnl.com
Major depressive disorder (MDD) remains a significant global health challenge. Patients failing to achieve remission despite multiple conventional therapeutic interventions (i.e., difficult-to-treat...
1
0
4
Just published: A study on the clinical effectiveness of transitioning to right lateral orbitofrontal cortex-TMS following unsuccessful use of sequential bilateral dorsolateral prefrontal-TMS for major depression. This research replicates our prior findings on the efficacy of
1
0
5
Single Treatment With MM120 (Lysergide) in Generalized Anxiety Disorder
jamanetwork.com
This randomized clinical trial assesses the dose-response relationship of MM120 (lysergide D-tartrate) vs placebo in adults with moderate to severe generalized anxiety disorder.
4
5
36
A single plant compound is showing results in mental health that psychiatry has never seen before. Stanford’s Dr. Nolan Williams joined me to explain why ibogaine could be a true game-changer. 🧵
20
47
403
Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder $CMPS https://t.co/DWYBTrRQrm
ir.compasspathways.com
Open-label Phase 2 study shows a single 25 mg COMP360 psilocybin dose was well tolerated, with no serious adverse events observed, and indicated both rapid and durable improvement in symptoms from...
1
3
21
[MRI-related anxiety] Pfurtscheller et al.: "Klimesch’s binary hierarchy model proposes a framework linking fast and slow brain oscillations with body oscillations." https://t.co/4G8AI71YQW
0
2
4
Just a handful of places still available for our TMS Certification Course and Masterclass. Hope to see you there! Sign-up here: https://t.co/9TvWioSqLX
1
0
6
Cure for your very late night bedtime may be as simple as dimming down evening light. This paper from 2018 showed people who cannot sleep early may be over-sensitive to light. https://t.co/C04Dwz73ys
1
12
51
🧠NEW PUBLICATION: Himes et al. present the largest pooled analysis of subcallosal cingulate deep brain stimulation for treatment-resistant depression—172 patients, 5-year follow-up, sustained symptom improvement. Read the full study:
brainstimjrnl.com
Deep brain stimulation (DBS) of the subcallosal cingulate (SCC) has been investigated clinically for treatment-resistant depression (TRD). Although the initial BROADEN study, a randomized controlled...
0
2
10
This is such a cool study and illustrates the complex nature and time course of post-exercise glycogen replenishment. Researchers had well-trained cyclists ride to glycogen depletion, then either fast for 12 hours or consume a massive 10 g/kg of carbs in the 12 hours
18
28
301
From Loomis’ mansion ➡️ @elonmusk @neuralink surgical robots ➡️ Altman’s new Merge Labs. Nearly a century later, we can train, regulate & stream brain activity. The question isn’t “if” but how — and for whom. Read the editorial with Niels Birbaumer and Tato Sokhadze here:
1
0
0
Niels Birbaumer pushed it further: Slow Cortical Potentials for epilepsy & ADHD First BCIs for ALS patients to say “yes”/“no” with brainwaves Ethics: many locked-in patients report high quality of life once given a voice.
1
0
0
Then came Joe Kamiya (1950s) — showing humans could control alpha waves on command. And Barry Sterman (1960s) — training cats on “SMR rhythms” & discovering seizure resistance. Their work turned EEG from curiosity ➡️ therapy.
1
0
0
Meet Alfred Lee Loomis — financier, inventor, eccentric. In his Tuxedo Park mansion, he built one of America’s first EEG labs. In 1935, he discovered sleep spindles + conditioned alpha rhythms with sound & hypnosis. A banker hacking brainwaves.
1
0
0
A Wall Street tycoon in the 1930s accidentally kick-started neurofeedback + BCIs /BMIs. Fast-forward to @neuralink, @synchroninc, @PrecisionNeuro_, @BlackrockNeuro_ — and now Merge Labs, backed by @sama. Our new editorial traces this wild arc 🧵👇
1
0
0
🚨ATTN: @SfNtweets attendees🚨 @JHPsychedelics is hosting a pre-SfN event: "The Trip between Bedside and Bench: Advancing Cross-Species Translation in Psychedelic Neuroscience"🍄 Registration is limited - reserve your spot ASAP! https://t.co/S9vmy5e1p0 RTs appreciated! Info👇
hopkinspsychedelic.org
2
15
29
Exciting work! Looks like we’re in an arms race… who can cram most pulses in a day/week…😁 SAINT, ONE-D, and here SAINT style dual protocol, what is next?
How far can we push transcranial magnetic stimulation (TMS) for those most in need? Our new accelerated TMS protocol delivers more pulses than has ever previously been reported, enabling a patient to cancel planned deep brain stimulation surgery. https://t.co/H1GSaY3S4d
0
0
1